Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Palbociclib> ?p ?o. }
Showing items 1 to 42 of
42
with 100 items per page.
- Palbociclib abstract "Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer.In a phase 2 trial reported at the April 2014 annual meeting of the American Association for Cancer Research, palbociclib was shown to significantly slow the progression of advanced cancer, but was not shown to have a statistically significant effect on increasing patients' overall survival times.It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.".
- Palbociclib atcPrefix "None".
- Palbociclib iupacName "6-Acetyl-8-cyclopentyl-5-methyl-2-{[5-(1-piperazinyl)-2-pyridinyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one".
- Palbociclib pubchem "5330286".
- Palbociclib thumbnail Palbociclib.svg?width=300.
- Palbociclib wikiPageID "39476963".
- Palbociclib wikiPageRevisionID "604916426".
- Palbociclib atcPrefix "None".
- Palbociclib c "24".
- Palbociclib chemspiderid "4487437".
- Palbociclib drugName "Palbociclib".
- Palbociclib h "29".
- Palbociclib inchi "1".
- Palbociclib inchikey "AHJRHEGDXFFMBM-UHFFFAOYAM".
- Palbociclib iupacName "6".
- Palbociclib legalStatus "Investigational".
- Palbociclib molecularWeight "447.533".
- Palbociclib n "7".
- Palbociclib o "2".
- Palbociclib pubchem "5330286".
- Palbociclib smiles "O=C2NC5CCCC5".
- Palbociclib stdinchi "1".
- Palbociclib stdinchikey "AHJRHEGDXFFMBM-UHFFFAOYSA-N".
- Palbociclib synomys "PD-0332991".
- Palbociclib subject Category:Experimental_cancer_drugs.
- Palbociclib subject Category:Piperazines.
- Palbociclib subject Category:Protein_kinase_inhibitors.
- Palbociclib subject Category:Pyridines.
- Palbociclib subject Category:Pyridopyrimidines.
- Palbociclib type Drug.
- Palbociclib type FunctionalSubstance.
- Palbociclib comment "Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer.In a phase 2 trial reported at the April 2014 annual meeting of the American Association for Cancer Research, palbociclib was shown to significantly slow the progression of advanced cancer, but was not shown to have a statistically significant effect on increasing patients' overall survival times.It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.".
- Palbociclib label "Palbociclib".
- Palbociclib label "Palbociclib".
- Palbociclib sameAs Palbociclib.
- Palbociclib sameAs m.0vptdjp.
- Palbociclib sameAs Q15269707.
- Palbociclib sameAs Q15269707.
- Palbociclib wasDerivedFrom Palbociclib?oldid=604916426.
- Palbociclib depiction Palbociclib.svg.
- Palbociclib isPrimaryTopicOf Palbociclib.
- Palbociclib name "Palbociclib".
